← back to search

Xia Chuai

Hebei Medical University · CN
Area of research
Epidemiology · Immunology
Research interest
Research interests include Immunotherapy and Immune Responses, Hepatitis B Virus Studies, Herpesvirus Infections and Treatments, and Viral Infections and Immunology Research.
h-index
15
citations
873
works
53
NIH funding
primary concept
email

Recent publications

Monkeypox virus induces ferroptosis to facilitate viral replication and promotes inflammatory responses
Emerging Microbes & Infections 2025cited by 6position: firstdoi
Roles of hypoxia inducible factors in viral infection: Are they a potential therapeutic target?
Virulence 2025cited by 3position: middledoi
Insulin‐Like Growth Factor 2 mRNA Binding Protein 2 Promotes HBV‐Associated Hepatocellular Carcinoma Progression by Enhancing Heme Oxygenase 1 Stability in an M <sup>6</sup> A‐dependent Manner
MedComm 2025cited by 1position: lastdoi
HBV Precore G1896A Mutation Promotes Malignancy of Hepatocellular Carcinoma by Activating Endoplasmic Reticulum Stress to Enhance Aerobic Glycolysis
MedComm 2025cited by 0position: middledoi
N6-Methyladenosine Positively Regulates Coxsackievirus B3 Replication
Viruses 2024cited by 8position: lastdoi
Bronchoalveolar Lavage Fluid Metagenomic Second-Generation Sequencing Assists in Guiding the Treatment of Visceral Leishmaniasis: A Case Report
Infection and Drug Resistance 2024cited by 1position: middledoi
HBV precore G1896A mutation promotes growth of hepatocellular carcinoma cells by activating ERK/MAPK pathway
Virologica Sinica 2023cited by 15position: middledoi
Ferrets: A powerful model of SARS-CoV-2
动物学研究 2023cited by 12position: middledoi
Analysis of multidrug‐resistant determinants of clinically isolated <i>Acinetobacter baumannii</i> CYZ via whole genome sequencing
Microbiology and Immunology 2023cited by 0position: firstdoi
Monkeypox virus: a re-emergent threat to humans
Virologica Sinica 2022cited by 300position: middledoi
Hold Breath: Autonomic Neural Regulation of Innate Immunity to Defend Against SARS-CoV-2 Infection
Frontiers in Microbiology 2022cited by 3position: lastdoi
Long-term asymptomatic SARS-CoV-2 infection associated with deficiency on multiple immune cells
Biosafety and Health 2022cited by 1position: middledoi
Clinical Value of Serum Neuron‐Specific Enolase Combined with Serum S100B Protein in the Diagnosis of Systemic Lupus Erythematosus
Contrast Media & Molecular Imaging 2022cited by 1position: lastdoi
Regulation of Antiviral Immune Response by N6-Methyladenosine of mRNA
Frontiers in Microbiology 2021cited by 13position: lastdoi
Comparative study on virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients
Science China Life Sciences 2020cited by 131position: middledoi
Characteristic antimicrobial resistance of clinically isolated Stenotrophomonas maltophilia CYZ via complete genome sequence
Journal of Global Antimicrobial Resistance 2020cited by 17position: lastdoi
Legionella feeleii: pneumonia or Pontiac fever? Bacterial virulence traits and host immune response
Medical Microbiology and Immunology 2018cited by 17position: middledoi
The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens
Vaccine 2018cited by 8position: firstdoi
HBV antigen and DNA loss from mouse serum is associated with novel vaccine-induced HBV surface antigen-specific cell-mediated immunity and cytokine production
Antiviral Research 2018cited by 5position: firstdoi
Recombinant vaccinia vector-based vaccine (Tiantan) boosting a novel HBV subunit vaccine induced more robust and lasting immunity in rhesus macaques
Vaccine 2017cited by 8position: middledoi
Protective efficacy and hepatitis B virus clearance in mice enhanced by cell‐mediated immunity with novel prime‐boost regimens
Journal of Viral Hepatitis 2016cited by 5position: firstdoi
Anti-HBV immunity in mice and macaques and protective potency elicited by a novel protein and recombinant adenoviral-based HBV vaccine
Journal of Clinical Virology 2015cited by 0position: firstdoi
Poly(I:C)/Alum Mixed Adjuvant Priming Enhances HBV Subunit Vaccine-Induced Immunity in Mice When Combined with Recombinant Adenoviral-Based HBV Vaccine Boosting
PLoS ONE 2013cited by 41position: firstdoi
Optimisation of Prime–Boost Immunization in Mice Using Novel Protein-Based and Recombinant Vaccinia (Tiantan)-Based HBV Vaccine
PLoS ONE 2012cited by 21position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hongxiu Qiao · Hebei Medical University10 papers (2020–2025)Wenjie Tan · Hebei Medical University7 papers (2012–2018)Yan Zhao · Jiangxi Maternal and Child Health Hospital7 papers (2018–2025)Yao Deng · Kunming University of Science and Technology6 papers (2012–2018)Zhiyun Gao · Hebei Medical University6 papers (2018–2025)Sandra Chiu · University of Science and Technology of China6 papers (2022–2025)Baoxin Zhao · Hebei Medical University5 papers (2021–2025)Li Ruan · Fujian Normal University5 papers (2012–2017)Zhiyun Gao · Hebei Medical University4 papers (2021–2024) · 4 papers (2013–2018)Yan Cui · Beihua University4 papers (2023–2025)Weijie Wang · Tianjin Tianhe Hospital3 papers (2023–2025)Junhua Feng · Hebei Medical University2 papers (2020–2023)Hong Chen · Sun Yat-sen University Cancer Center2 papers (2012–2018)Bo Wen · Nanyang Technological University2 papers (2012–2013)Zhanjun Guo · Hebei Medical University2 papers (2023–2025)Wang Chang-le · Hebei Medical University2 papers (2023–2023)Yan Zhao · Hainan University2 papers (2020–2023) · 2 papers (2018–2018)Yan Zhao · Tianjin Agricultural University2 papers (2021–2024)